Kimberly Malloy to Female
This is a "connection" page, showing publications Kimberly Malloy has written about Female.
Connection Strength
0.152
-
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study. PLoS One. 2025; 20(2):e0316198.
Score: 0.019
-
Depression and Incident Hypertension: The Strong Heart Family Study. Prev Chronic Dis. 2025 Jan 16; 22:E06.
Score: 0.019
-
Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study. PLoS One. 2024; 19(4):e0302464.
Score: 0.018
-
The COVID-19 pandemic and OBGYN residency training: We have a problem and it's not just masks. BMC Med Educ. 2024 Apr 05; 24(1):377.
Score: 0.018
-
Ambulatory Activity and Risk of Premature Mortality Among Young and Middle-aged American Indian Individuals. JAMA Netw Open. 2023 05 01; 6(5):e2311476.
Score: 0.017
-
Evaluating situational judgment test use and diversity in admissions at a southern US medical school. PLoS One. 2023; 18(2):e0280205.
Score: 0.017
-
Cancer mortality in a population-based cohort of American Indians - The strong heart study. Cancer Epidemiol. 2021 10; 74:101978.
Score: 0.015
-
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One. 2013; 8(2):e55730.
Score: 0.008
-
Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol Oncol. 2012 May; 125(2):458-69.
Score: 0.008
-
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Reprod Sci. 2011 Sep; 18(9):832-41.
Score: 0.007
-
Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecol Oncol. 2010 Jan; 116(1):92-8.
Score: 0.007